CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The project seeks to identify biomarkers for schizophrenia and bipolar disorder to enable early diagnosis and improve treatment outcomes. By developing a diagnostic tool for biological samples, it aims to enhance understanding of these mental health conditions.
Schizophrenia and bipolar affective disorder are a major burden to affected individuals and their families and to society at large.
These two severe mental illnesses affect at least 2% of the population worldwide, and whilst 50% of sufferers do not receive adequate treatment, they cost hundreds of billions in healthcare provision, treatments and lost earnings.
The current diagnosis of schizophrenia (and bipolar disorder etc.) is rather subjective, not only because of the complex spectrum of symp…
Psynova Neurotech Ltd
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE
United Kingdom, Cambridge
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
ZENTRALINSTITUT FUER SEELISCHE GESUNDHEIT
Germany, Mannheim
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Germany, MUENSTER
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Germany, Reutlingen
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
